Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Pharma
Daiichi Sankyo secures COVID vaccine supply pact in Japan
As Daiichi Sankyo holds out for local approval of its omicron-adapted mRNA shot for COVID-19, the company secured a supply pact in its native Japan.
Fraiser Kansteiner
Nov 17, 2023 9:45am
Manufacturer NTx attracts big-name investors for $47.5M round
Nov 16, 2023 10:27am
Gates Foundation lays out $40M for African mRNA shot production
Oct 9, 2023 2:27pm
Fierce 50: Breakthroughs honorees
Oct 2, 2023 4:00am
WuXi plots hundreds of hires at first standalone vaccine plant
Sep 26, 2023 3:35pm
MilliporeSigma christens €28M pair of mRNA production plants
Sep 26, 2023 12:38pm
